Search Articles

On 28 September 2026, India’s Directorate General of Trade Remedies (DGTR), under the Ministry of Commerce and Industry, initiated an anti-dumping investigation into imports of Penicillin G (Pen-G) and its salts from China. The probe followed an application by domestic manufacturer Lyfius Pharma Private Limited, which alleged that the imports were causing material retardation to the establishment of India’s domestic industry.

The Spices Board India and the ICAR-Indian Institute of Spices Research (IISR) held a national seminar in Kochi, Kerala, on 9 October 2026 to discuss the proposed Bharat Spice Map. The initiative combines geospatial technology, scientific research and market intelligence to map spice-growing regions, varieties and quality characteristics.

The Reserve Bank of India (RBI) raised the minimum daily Cash Reserve Ratio (CRR) maintenance requirement for scheduled banks from 90% to 99% of the prescribed CRR. The change takes effect from the reporting fortnight beginning 16 October 2026, while the overall CRR remains unchanged at 3%. The RBI announced the measure on 9 October 2026 amid banking-system surplus liquidity of about ₹3.88 lakh crore as of 8 October.

On 8 October 2026, the National Pharmaceutical Pricing Authority (NPPA) approved in principle a 30% trade-margin cap, based on the Maximum Retail Price (MRP), for identified non-scheduled anti-cancer medicines. The proposed measure is projected to reduce prices by 20% to 70% and save patients an estimated ₹2,500 crore annually.

The World Bank ranked India among the top 10 emerging-market performers in artificial intelligence readiness on 6 October 2026. The assessment appeared in the report titled India and Artificial Intelligence: Seizing the Development Opportunity. The report linked India’s position to its technical workforce, globally integrated information technology sector, and digital public infrastructure.